Sonic Incytes, a Canadian artificial intelligence (AI)-assisted medical imaging company based out of Vancouver, British Columbia, is looking to change the way liver disease is screened and monitored globally. Their flagship, FDA cleared device, Velacur™, is revolutionizing the diagnosis and management of chronic liver disease. Their proprietary technology that grew into Velacur was originally developed by researchers at the University of British Columbia (UBC).
Medical technology fellowship program, established by Sunnybrook in Toronto, launches second program with the Nova Scotia Health Innovation Hub
Medventions, established by Sunnybrook in Toronto, launches second program with the Nova Scotia Health Innovation Hub
The Radialis PET Imager: Thunder Bay health innovation ecosystem nurtures cutting-edge healthcare technology
When you think of cities housing and building transformational medical technology (medtech), your first guess probably isn’t ‘the city with a giant heart’. Nestled on the northwestern corner of Lake Superior, Thunder Bay, Ontario, is home to one of Canada’s most promising medtech companies specializing in positron emission tomography medical device manufacturing, Radialis.
INOVAIT announces third round of funding for artificial intelligence and image-guided therapy projects
June 21, 2023 | Toronto, ON – INOVAIT, the pan-Canadian network for image-guided therapy (IGT) hosted by Sunnybrook...
Sunnybrook’s Medventions program expands to Atlantic Canada with the Nova Scotia Health Innovation Hub
June 19 2023 | Today, Sunnybrook Research Institute (SRI) and INOVAIT are proud to announce the expansion of...
IGT Lecture Series
Regulating AI in Image-Guided Therapy
Follow INOVAIT on Social Media